Trovagene, Inc., a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including colorectal cancer, prostate cancer and leukemia, announced company highlights and financial results for the first quarter ended March 31, 2020.